Cardiovascular (CV) risk and mortality associated with spondyloarthritis (SpA) remain controversial. Herein, we performed a meta‐analysis of the latest large‐scale population‐based studies to demonstrate the elevated risk of CV disease… Click to show full abstract
Cardiovascular (CV) risk and mortality associated with spondyloarthritis (SpA) remain controversial. Herein, we performed a meta‐analysis of the latest large‐scale population‐based studies to demonstrate the elevated risk of CV disease and mortality in patients with SpA than in the general population.
               
Click one of the above tabs to view related content.